Open Letter: Community Statement on Accelerating Access to Lenacapavir by Gilead

We are sharing a statement from a community and civil society leaders, advocates and activists meeting on long-acting drugs for the prevention and treatment of HIV which took place in Nairobi in April 2023.
In this statement, the community demands rapid action from Gilead to make Lenacapavir accessible in low and middle-income countries without further delay!

See the statement below:

LEN Nairobi Long-Acting Community Meeting Statement_Gilead Download

Edit

Published: July 18, 2023

Membership of AfroCAB is free and open to HIV-positive people and community advocates.
Meetings

AfroCAB meetings are free and limited to 30 people. Meetings are interactive, with questions, discussions and time to network. Meetings are held in various locations within Africa.
Pages

AfroCAB

Open Letter: Community Statement on Accelerating Access to Lenacapavir by Gilead

Meetings

Pages